Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$124.46
-5.4%
$131.19
$99.71
$141.23
$215.85B0.75.90 million shs10.78 million shs
Bank of America Co. stock logo
BAC
Bank of America
$34.37
-7.7%
$43.99
$33.69
$48.08
$261.32B1.3237.80 million shs107.69 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$208.03
-6.1%
$230.78
$203.51
$251.99
$59.73B0.351.65 million shs6.62 million shs
Boston Scientific Co. stock logo
BSX
Boston Scientific
$89.78
-8.9%
$102.14
$66.80
$107.17
$132.78B0.776.18 million shs22.57 million shs
Intuit Inc. stock logo
INTU
Intuit
$561.53
-6.2%
$596.37
$553.24
$714.78
$156.98B1.271.54 million shs3.33 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$451.58
-8.7%
$547.83
$364.17
$616.00
$160.84B1.551.54 million shs4.11 million shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$210.09
-8.1%
$255.80
$179.20
$280.25
$587.43B1.19.47 million shs27.14 million shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.49
-5.1%
$1.72
$0.82
$3.38
$51.77M1.61.78 million shs1.03 million shs
Medtronic plc stock logo
MDT
Medtronic
$82.86
-5.7%
$91.01
$75.96
$96.25
$106.28B0.86.60 million shs12.03 million shs
Stryker Co. stock logo
SYK
Stryker
$346.14
-6.0%
$382.64
$314.93
$406.19
$132.12B0.951.32 million shs3.96 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.40%-0.07%-4.42%+15.59%+18.20%
Bank of America Co. stock logo
BAC
Bank of America
-11.13%-12.68%-12.56%-16.96%-0.62%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-2.19%-3.13%-1.28%-3.01%-9.08%
Boston Scientific Co. stock logo
BSX
Boston Scientific
-1.56%-2.22%-4.89%+8.62%+44.52%
Intuit Inc. stock logo
INTU
Intuit
-3.60%-2.73%+0.08%-5.03%-3.93%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-2.45%-2.62%-11.35%-7.60%+29.00%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
-7.11%-7.95%-8.54%-6.04%+15.28%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-7.65%+2.61%+15.44%-26.64%+24.60%
Medtronic plc stock logo
MDT
Medtronic
-1.22%-1.25%-5.59%+8.57%+3.40%
Stryker Co. stock logo
SYK
Stryker
-2.57%+0.07%-5.68%+1.83%+4.76%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.961 of 5 stars
3.44.04.24.53.52.52.5
Bank of America Co. stock logo
BAC
Bank of America
4.9802 of 5 stars
4.43.04.23.32.81.73.8
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.8676 of 5 stars
3.54.04.24.03.03.31.3
Boston Scientific Co. stock logo
BSX
Boston Scientific
4.5233 of 5 stars
3.54.00.04.23.52.51.3
Intuit Inc. stock logo
INTU
Intuit
4.9228 of 5 stars
4.45.03.33.03.42.51.3
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.767 of 5 stars
4.33.00.04.03.62.51.9
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.8803 of 5 stars
3.35.04.22.13.22.52.5
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
1.5494 of 5 stars
3.52.00.00.01.90.00.6
Medtronic plc stock logo
MDT
Medtronic
4.5678 of 5 stars
3.24.03.34.02.92.50.6
Stryker Co. stock logo
SYK
Stryker
4.6809 of 5 stars
3.43.03.34.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.9410.83% Upside
Bank of America Co. stock logo
BAC
Bank of America
2.83
Moderate Buy$48.3140.55% Upside
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
3.00
Buy$278.2933.77% Upside
Boston Scientific Co. stock logo
BSX
Boston Scientific
3.00
Buy$108.9121.32% Upside
Intuit Inc. stock logo
INTU
Intuit
2.70
Moderate Buy$718.0027.86% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$611.8635.49% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.53
Moderate Buy$254.8321.30% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00504.03% Upside
Medtronic plc stock logo
MDT
Medtronic
2.44
Hold$96.0715.94% Upside
Stryker Co. stock logo
SYK
Stryker
2.80
Moderate Buy$421.9021.89% Upside

Current Analyst Ratings Breakdown

Latest ISRG, ABT, BAC, BDX, BSX, INTU, JPM, MDT, MBOT, and SYK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2025
Bank of America Co. stock logo
BAC
Bank of America
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$53.00 ➝ $50.00
4/4/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$268.00 ➝ $264.00
4/3/2025
Bank of America Co. stock logo
BAC
Bank of America
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$49.50 ➝ $43.50
4/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$285.00 ➝ $284.00
4/1/2025
Bank of America Co. stock logo
BAC
Bank of America
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$51.00 ➝ $48.00
4/1/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$273.00 ➝ $265.00
3/31/2025
Intuit Inc. stock logo
INTU
Intuit
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$800.00 ➝ $735.00
3/24/2025
Bank of America Co. stock logo
BAC
Bank of America
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$54.00 ➝ $50.00
3/21/2025
Stryker Co. stock logo
SYK
Stryker
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$442.00 ➝ $442.00
3/18/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$707.00 ➝ $600.00
3/17/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 4/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.15$5.36 per share23.22$22.36 per share5.57
Bank of America Co. stock logo
BAC
Bank of America
$101.89B2.56$3.00 per share11.45$35.50 per share0.97
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.64B2.89$19.33 per share10.76$89.57 per share2.32
Boston Scientific Co. stock logo
BSX
Boston Scientific
$16.75B7.93$3.11 per share28.86$14.91 per share6.02
Intuit Inc. stock logo
INTU
Intuit
$17.17B9.14$14.14 per share39.71$65.77 per share8.54
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B19.26$5.95 per share75.93$46.41 per share9.73
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$169.44B3.47$17.33 per share12.12$116.13 per share1.81
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.38 per shareN/A
Medtronic plc stock logo
MDT
Medtronic
$33.20B3.20$6.79 per share12.21$38.69 per share2.14
Stryker Co. stock logo
SYK
Stryker
$22.60B5.85$13.51 per share25.62$54.08 per share6.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6516.2721.722.5231.95%20.74%11.19%4/16/2025 (Estimated)
Bank of America Co. stock logo
BAC
Bank of America
$27.13B$3.2210.677.881.2114.10%10.29%0.84%4/15/2025 (Estimated)
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$6.0234.5613.301.638.47%15.74%7.29%5/1/2025 (Estimated)
Boston Scientific Co. stock logo
BSX
Boston Scientific
$1.85B$1.2571.8227.792.7911.07%17.80%9.85%4/23/2025 (Estimated)
Intuit Inc. stock logo
INTU
Intuit
$2.96B$10.7254.5235.012.8517.59%18.25%10.42%5/22/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.4170.4559.185.8527.81%14.55%12.88%4/22/2025 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$58.47B$19.7410.6410.822.8320.96%16.99%1.31%4/11/2025 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$10.74M-$0.74N/AN/AN/AN/A-218.30%-158.17%5/13/2025 (Estimated)
Medtronic plc stock logo
MDT
Medtronic
$3.68B$3.2925.1914.212.2212.83%14.07%7.70%5/21/2025 (Estimated)
Stryker Co. stock logo
SYK
Stryker
$2.99B$7.7644.6123.342.9313.25%23.58%11.37%4/29/2025 (Estimated)

Latest ISRG, ABT, BAC, BDX, BSX, INTU, JPM, MDT, MBOT, and SYK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025N/A
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.28N/AN/AN/A$5.35 billionN/A
4/29/2025N/A
Stryker Co. stock logo
SYK
Stryker
$2.76N/AN/AN/A$5.68 billionN/A
4/23/2025N/A
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.67N/AN/AN/A$4.57 billionN/A
4/22/2025N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71N/AN/AN/A$2.19 billionN/A
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
4/15/2025N/A
Bank of America Co. stock logo
BAC
Bank of America
$0.80N/AN/AN/A$26.83 billionN/A
4/11/2025N/A
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.57N/AN/AN/A$43.62 billionN/A
3/26/2025Q4 2024
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.18-$0.20-$0.02-$0.20N/AN/A
2/18/2025Q3 2025
Medtronic plc stock logo
MDT
Medtronic
$1.36$1.39+$0.03$1.01$8.33 billion$8.29 billion
2/5/2025Q1 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.00$3.43+$0.43$1.04$5.13 billionN/A
2/5/2025Q4 2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.65$0.70+$0.05$0.38$4.42 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.90%+7.17%30.85%54 Years
Bank of America Co. stock logo
BAC
Bank of America
$1.043.03%+8.63%32.30%11 Years
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.00%+5.00%69.10%53 Years
Boston Scientific Co. stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Intuit Inc. stock logo
INTU
Intuit
$4.160.74%+15.17%38.81%13 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$5.602.67%+8.10%28.37%15 Years
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Medtronic plc stock logo
MDT
Medtronic
$2.803.38%+4.14%85.11%48 Years
Stryker Co. stock logo
SYK
Stryker
$3.360.97%+7.82%43.30%32 Years

Latest ISRG, ABT, BAC, BDX, BSX, INTU, JPM, MDT, MBOT, and SYK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
3/18/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.402.38%4/4/20254/4/20254/30/2025
2/5/2025
Stryker Co. stock logo
SYK
Stryker
quarterly$0.840.86%3/31/20253/31/20254/30/2025
2/20/2025
Intuit Inc. stock logo
INTU
Intuit
quarterly$1.040.7%4/10/20254/10/20254/18/2025
3/6/2025
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.703%3/28/20253/28/20254/11/2025
1/28/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.041.67%3/10/20253/10/20253/31/2025
1/29/2025
Bank of America Co. stock logo
BAC
Bank of America
quarterly$0.262.23%3/7/20253/7/20253/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Bank of America Co. stock logo
BAC
Bank of America
1.04
0.78
0.78
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.13
0.63
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.41
1.08
1.02
Intuit Inc. stock logo
INTU
Intuit
0.31
1.24
1.24
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.07
3.22
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.24
0.88
0.89
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
3.64
3.64
Medtronic plc stock logo
MDT
Medtronic
0.48
1.90
1.39
Stryker Co. stock logo
SYK
Stryker
0.59
1.95
1.32
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Bank of America Co. stock logo
BAC
Bank of America
217,0007.60 billion7.65 billionOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
77,000287.14 million286.10 millionOptionable
Boston Scientific Co. stock logo
BSX
Boston Scientific
45,0001.48 billion1.47 billionOptionable
Intuit Inc. stock logo
INTU
Intuit
18,800279.56 million272.42 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
12,100356.18 million352.97 millionOptionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
293,7002.80 billion2.77 billionOptionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2034.74 million25.64 millionOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
Stryker Co. stock logo
SYK
Stryker
51,000381.69 million359.07 millionOptionable

Recent News About These Companies

Stryker Co. stock logo
AIA Group Ltd Buys Shares of 819 Stryker Co. (NYSE:SYK)
Stryker completes sale of U.S. spinal implants business

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$124.46 -7.17 (-5.45%)
Closing price 03:59 PM Eastern
Extended Trading
$125.00 +0.54 (+0.43%)
As of 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Bank of America stock logo

Bank of America NYSE:BAC

$34.37 -2.85 (-7.65%)
Closing price 03:59 PM Eastern
Extended Trading
$34.17 -0.20 (-0.59%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates in four segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets. The Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, non-interest and interest-bearing checking accounts, and investment accounts and products; credit and debit cards; residential mortgages, and home equity loans; and direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The GWIM segment provides investment management, brokerage, banking, and trust and retirement products and services; wealth management solutions; and customized solutions, including specialty asset management services. The Global Banking segment offers lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, short-term investing options, and merchant services; working capital management solutions; debt and equity underwriting and distribution, and merger-related and other advisory services; and fixed-income and equity research, and certain market-based services. The Global Markets segment provides market-making, financing, securities clearing, settlement, and custody services; securities and derivative products; and risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. Bank of America Corporation was founded in 1784 and is based in Charlotte, North Carolina.

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$208.03 -13.56 (-6.12%)
Closing price 03:59 PM Eastern
Extended Trading
$210.18 +2.15 (+1.03%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$89.78 -8.73 (-8.86%)
Closing price 03:59 PM Eastern
Extended Trading
$89.96 +0.18 (+0.20%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Intuit stock logo

Intuit NASDAQ:INTU

$561.53 -37.00 (-6.18%)
Closing price 04:00 PM Eastern
Extended Trading
$560.36 -1.17 (-0.21%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business & Self-Employed segment provides QuickBooks services, that includes financial and business management online services and desktop software, payroll solutions, time tracking, merchant payment processing solutions, and financing for small businesses; and Mailchimp services, such as e-commerce, marketing automation, and customer relationship management. This segment also offers QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; and QuickBooks Self-Employed solution; payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; and financial supplies and financing for small businesses, as well as electronic filing of federal and state income tax returns. The Consumer segment provides TurboTax income tax preparation products and services. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProTax segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$451.58 -43.03 (-8.70%)
Closing price 04:00 PM Eastern
Extended Trading
$454.02 +2.44 (+0.54%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

JPMorgan Chase & Co. stock logo

JPMorgan Chase & Co. NYSE:JPM

$210.09 -18.60 (-8.13%)
Closing price 03:59 PM Eastern
Extended Trading
$210.01 -0.08 (-0.04%)
As of 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.49 -0.08 (-5.10%)
Closing price 04:00 PM Eastern
Extended Trading
$1.48 0.00 (-0.34%)
As of 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Medtronic stock logo

Medtronic NYSE:MDT

$82.86 -5.03 (-5.72%)
Closing price 03:59 PM Eastern
Extended Trading
$82.50 -0.36 (-0.44%)
As of 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker stock logo

Stryker NYSE:SYK

$346.14 -22.01 (-5.98%)
Closing price 03:59 PM Eastern
Extended Trading
$347.00 +0.86 (+0.25%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.